Literature DB >> 7747724

Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus.

B I Freedman1, A B Tuttle, B J Spray.   

Abstract

Nephropathy clusters in Pima Indian families with non-insulin-dependent diabetes mellitus (NIDDM), suggesting that susceptibility to nephropathy is distinct from NIDDM per se. The authors compared the family history of end-stage renal disease (ESRD) from 52 African-American patients with NIDDM-induced ESRD (cases) with 45 age-, sex-, and and race-matched non-insulin-dependent diabetics without nephropathy (controls) to assess whether the risk of renal disease was independent from NIDDM in African-Americans as well. Thirty-seven percent (19 of 52) of NIDDM-induced ESRD patients had either a first-, second-, or third-degree relative with ESRD, in contrast to only 7% (3 of 45) of diabetic controls. African-American individuals with NIDDM were at eightfold increased risk for developing subsequent ESRD in the presence of a close relative with ESRD (odds ratio = 8.06; 95% confidence interval, 2.2 to 29.6; P < or = 0.0005). No significant differences were observed in yearly income, years of formal education, total serum cholesterol level, prevalence of smoking, or hypertension between the groups. Diabetic control (assessed by glycosylated hemoglobin and random glucose levels) was suboptimal in nonrenal disease controls, suggesting that hyperglycemia alone fails to cause nephropathy in patients with NIDDM. Family size was unlikely to have influenced the results because diabetic cases had significantly fewer first-degree relatives than did diabetic controls. Familial clustering of ESRD is present in certain African-American families with NIDDM. Differences in family size and degree of diabetic control are unlikely to account for the differences observed between families.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7747724     DOI: 10.1016/0272-6386(95)90546-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  66 in total

Review 1.  Complications of diabetes: renal disease and promotion of self-management.

Authors:  A Melville; R Richardson; D Lister-Sharp; A McIntosh
Journal:  Qual Health Care       Date:  2000-12

2.  Screening and prevention of chronic kidney disease.

Authors:  Errol D Crook; David O Washington; John M Flack
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

3.  The new era of APOL1-associated glomerulosclerosis.

Authors:  Barry I Freedman; Carl D Langefeld
Journal:  Nephrol Dial Transplant       Date:  2012-02-02       Impact factor: 5.992

Review 4.  Risk predictors in patients with diabetic nephropathy.

Authors:  P Fioretto; M L Caramori; M Dalla Vestra; M Mauer
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 5.  Microalbuminuria in diabetes: focus on cardiovascular and renal risk reduction.

Authors:  George L Bakris; James R Sowers
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 6.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 7.  Genetics of diabetic nephropathy in the Pima Indians.

Authors:  G Imperatore; W C Knowler; R G Nelson; R L Hanson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 8.  Genetics of diabetes complications.

Authors:  Donald W Bowden
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

9.  Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy.

Authors:  P K Chandie Shaw; L A van Es; L C Paul; F R Rosendaal; J H M Souverijn; J P Vandenbroucke
Journal:  Diabetologia       Date:  2003-05-09       Impact factor: 10.122

10.  Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.

Authors:  Jun Ma; Meijian Guan; Donald W Bowden; Maggie C Y Ng; Pamela J Hicks; Janice P Lea; Lijun Ma; Chuan Gao; Nicholette D Palmer; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.